title: Gene structure and expression study of the SEDL gene for spondyloepiphyseal dysplasia tarda.
abstract: Spondyloepiphyseal dysplasia tarda (SEDL) is an X-linked recessive disorder of endochondral bone formation caused by mutations in the SEDL gene. Here we present the structural analysis and subcellular localization of human SEDL. The SEDL gene is composed of six exons and spans a genomic region of approximately 20 kb in Xp22. It contains four Alu sequences in its 3' UTR and an alternatively spliced MER20 sequence in its 5' UTR (exon 2). Complex alternative splicing was detected for exon 4. Altogether seven SEDL pseudogenes were detected in the human genome: SEDLP1, a transcribed retropseudogene (or retro-xaptonuon) on chromosome 19q13.4 with potential to encode a protein identical to that of the SEDL gene; SEDLP2, another retropseudogene (not transcribed) on chromosome 8; and five truncated pseudogenes, SEDLP3-SEDLP7, on chromosome Yq11.23. Based on the knowledge of the yeast SEDL ortholog we speculated that the SEDL protein may participate along the ER-to-Golgi transport compartments. To test this hypothesis we performed transient transfection studies with tagged recombinant mammalian SEDL proteins in Cos-7 cells. The tagged SEDL proteins localized to perinuclear structures that partly overlapped with the intermediate ER-Golgi compartment (ERGIC; or vesicular tubular complex, VTC). Two human SEDL mutations (157-158delAT and C271T(STOP)) introduced into SEDL FLAG and GFP constructs led to the misplacement of the SEDL protein primarily to the cell nucleus and partially to the cytoplasm. Based on these experiments we suggest that the COOH end of the SEDL protein might be responsible for proper targeting of SEDL along the ER-Golgi membrane compartments (including Golgi and ERGIC/VTC).
authors.affiliation: Centre for Medical Genetics, Women's and Children's Hospital, Adelaide, South Australia, 5006, Australia. jgecz@medicine.adelaide.edu.au
authors.forename: J
authors.initials: J
authors.lastname: Gécz
authors.forename: M A
authors.initials: MA
authors.lastname: Hillman
authors.forename: A K
authors.initials: AK
authors.lastname: Gedeon
authors.forename: T C
authors.initials: TC
authors.lastname: Cox
authors.forename: E
authors.initials: E
authors.lastname: Baker
authors.forename: J C
authors.initials: JC
authors.lastname: Mulley
mesh_terms: D017398:Alternative Splicing; D002352:Carrier Proteins / Q000235:genetics* / Q000378:metabolism*; D020224:Expressed Sequence Tags; D016368:Frameshift Mutation; D015894:Genome, Human; D006801:Humans; D026901:Membrane Transport Proteins; D010009:Osteochondrodysplasias / Q000235:genetics*; D011544:Pseudogenes; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012689:Sequence Homology, Nucleic Acid; D013347:Subcellular Fractions; D014157:Transcription Factors
chemical_list: D002352:Carrier Proteins; D026901:Membrane Transport Proteins; D011994:Recombinant Proteins; C120759:TRAPPC2 protein, human; D014157:Transcription Factors